NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a notice of award from the National Institute of General Medical Sciences for a Phase II Small Business Investigational Research grant to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.

The Plymouth, Mich.-based firm will use the three-year, $1.8 million grant also to identify biological pathway signatures for specific diseases and to identify pathway signatures for drugs in order to repurpose them, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.